Four Deaths Prompt FDA Safety Concerns About Novel Schizophrenia Drug

(MedPage Today) -- The FDA flagged a potential safety signal after four deaths were reported among patients with treatment-resistant schizophrenia who received investigational evenamide in clinical trials, Newron Pharmaceuticals said Thursday...